BNET Industries
resmed inc. - All News and Analysis
ResMed: Record Quarterly Revenues, Great Valuations
Seeking Alpha
- 2008-11-26
Zacks.com submits: ResMed Inc RMD announced record quarterly revenues and income. Shares are enticing as they trade at a discount to the industry averages. Company Description ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing....
ResMed Inc. F1Q09 (Qtr. End 09/30/08) Earnings Call Transcript
Seeking Alpha
- 2008-11-07
Question-and-Answer Session[Operator Instructions]. And your first question comes from the line of David Clair with Piper Jaffray. Please proceed. David Clair - Piper Jaffray Hi, guys. Congratulations. Kieran T. Gallahue - President and Chief Executive Officer Thank you. David Clair - Piper Jaffray Yeah. Just a question about the...
Earnings Preview: ResMed
Seeking Alpha
- 2008-11-05
ResMed Inc. RMD is expected to report Q1 earnings after the close Thursday with a conference call scheduled for 4:30 pm ET. Guidance Analysts are looking for a profit of 38c on revenue of $218M. The consensus is 34c to 41c for EPS, and revenue of $210M to $227M, according...
ResMed Beats Earnings Estimates; Back on Track
Seeking Alpha
- 2008-08-07
Robert Freedland submits: I am absolutely in love with Meridian Bioscience VIVO but with the latest quarter mildly disappointing, and the stock lagging while the rest of the market moves higher, I grew impatient yesterday and started looking for another vehicle for my investment purposes. Okay, it...
ResMed, Inc. F4Q08 (Qtr. End 06/30/08) Earnings Call Transcript
Seeking Alpha
- 2008-08-05
Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of Andrew Goodsall [UBS Securities]. Please proceed. Andrew Goodsall - UBS Securities Good morning guys. Thanks very much and very good results. Perhaps if I can just ask a couple of housekeeping questions, just I guess on FX, total...
ResMed, Inc. F3Q08 (Qtr. End 03/31/08) Earnings Call Transcript
Seeking Alpha
- 2008-05-02
Question-and-Answer SessionThank you sir. [Operator Instructions] Additionally, we would ask that you limit your self to one question and one follow-up question originally. Thank you and sir your first question will come from the line of Ben Andrew with William Blair. Please proceed. Benjamin Andrew - William Blair &...
ResMed, Inc. F2Q08 (Qtr. End 12/31/07) Earnings Call Transcript
Seeking Alpha
- 2008-05-01
Question-and-Answer SessionThank you. [Operator Instructions]. Your first question comes from the line of Joshua Zable of Natixis. Please proceed. Joshua Zable - Natixis Bleichroeder Hi, guys. Thanks for taking my call here. Peter, I take this opportunity to thank you for all your help over the years and Kieran...
ResMed, Inc. F2Q08 (Qtr. End 12/31/07) Earnings Call Transcript
Seeking Alpha
- 2008-02-07
Question-and-Answer SessionThank you. [Operator Instructions]. Your first question comes from the line of Joshua Zable of Natixis. Please proceed. Joshua Zable - Natixis Bleichroeder Hi, guys. Thanks for taking my call here. Peter, I take this opportunity to thank you for all your help over the years and Kieran...
ResMed, Inc. Q3 2007 Earnings Call Transcript
Seeking Alpha
- 2007-11-02
Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Paul Choi with Merrill Lynch. Go ahead. Paul Choi - Merrill Lynch Good afternoon, Peter. Peter Farrell Paul, how are you? Paul Choi - Merrill Lynch Fine, thank you. Let me first say congratulations to you and...
Frost & Sullivan Recognizes ResMed for Product Quality Leadership Award in the Sleep Therapy Market
- 2005-03-16
SAN FRANCISCO -- Frost & Sullivan today announced ResMed, Inc. (NYSE:RMD) as the recipient of the 2005 Product Quality Leadership of the Year Award for developing the S7 Elite CPAP product line for the sleep therapy market. Frost & Sullivan presents this Award each year to the company that...
Executive profile: Peter C. Farrell
- 2003-03-24
Peter C. Farrell, a former MIT professor, scientist, engineer, entrepreneur and avid art and music collector, drives his company with both the precision of his German-engineered Mercedes and the speed of his Porsche. The multifaceted Australian-born CEO and president of Poway-based ResMed Inc. knows classic literature equally as well as...
ResMed To Webcast Second Quarter 2003 Earnings Release Conference Call
- 2003-01-27
Business Editors SAN DIEGO--BUSINESS WIRE--Jan. 27, 2003 RESMED, INC. (NYSE:RMD), announced that on Monday, February 3, 2003, it will release its second quarter earnings results for the period ended December 31, 2002. The Earnings Press Release will be issued at approximately 1:15 p.m. PST and will be available...
SHARES IN AUSTRALIA'S RESMED RISE ON BUYBACK PLAN.
- 2002-06-07
SYDNEY, June 7 Asia Pulse - News of a major equity buyback plan have pushed triggered a rally in ResMed Inc (ASX:RMD), which were languishing at from 12-month lows. The sleep disorder technology company, which is dually-listed in Australia and the US, said its board had backed a...
ResMed to Webcast Third Quarter 2002 Earnings Release Conference Call
- 2002-04-22
Business Editors SAN DIEGO--BUSINESS WIRE--April 22, 2002 ResMed Inc. (NYSE:RMD), announced today that on Thursday, May 2, 2002, it will release its fiscal 2002 third quarter and nine months results for the period ended March 30, 2002. The Earnings Press Release will be issued at approximately 1:30...
ResMed to Webcast Second Quarter 2002 Earnings Release Conference Call
- 2002-01-28
Business Editors & Medical Writers SAN DIEGO--BUSINESS WIRE--Jan. 28, 2002 RESMED INC. (NYSE:RMD), announced today that on Wednesday, January 30, 2002, it will release its second quarter 2002 earnings results for the period ended December 31, 2001. The Earnings Press Release will be issued at approximately 1:30 p.m....
ResMed Inc. announces initial public offering
- 1995-06-02
NORTH RYDE, Australia--BUSINESS WIRE--June 2, 1995--ResMed Inc. ("ResMed" or "the company" NASDAQ/NMS: RESM) announced today an initial public offering of 3,000,000 shares of its Common Stock at a price of $11 per share.Of the 3,000,000 shares, 2,000,000 shares are being sold by the company and 1,000,000 are being sold by...
ResMed Inc. files registration statement for initial public offering
- 1995-04-12
NORTH RYDE, N.S.W., Australia--BUSINESS WIRE--April 12, 1995-- ResMed Inc. ("ResMed" or the "company") announced today that yesterday it filed a registration statement with the Securities and Exchange Commission for an initial public offering of 3,000,000 shares of common stock.The offering price is expected to be between $10 and $12 per...
Additional Resources
Research and Markets: ResMed Inc. Generated $835M, $716M, and $607M Worth of Revenue in the Fiscal Years Ending Approximately June 30, 2008, 2007, and 2006
- 2008-11-27
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/e8d368/resmed_inc_and_th) has announced the addition of the "ResMed Inc. and the U.S. Electromedical and Electrotherapeutic Apparatus Manufacturing Industry" company profile to their offering. The ResMed Inc. company report details the company's key financial data, business operations, technology and patent activities, financial benchmarks...
Zacks Releases Four Powerful "Buy" Stocks: ResMed, DeVry, Questor Pharmaceuticals and Carter's
- 2008-11-26
CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value....
ResMed
- 2008-11-17
ResMed said it had third-quarter net income of $28 million, up 16 percent from the like quarter of 2007. Revenue was $217.9 million, up 17 percent. Send any news of locally based public companies to Mike Allen via e-mail at mallen@sdbj.com. He can be reached at 858-277-6359...
Sort byClose
View by Content TypeClose
- Revenue (Fiscal Year) $835.3M
- Profit (Fiscal Year) $110.3M
- Incorporated: 1994
- CEO: Mr. Kieran T. Gallahue
ResMed is a holding company. Through its subsidiaries, Co. designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing, or SDB, and other respiratory disorders, including obstructive sleep apnea, or OSA. Co. produces Continuous Positive Airway Pressure or CPAP, Variable Positive Airway Pressure and AutoSet systems for the titration and treatment of SDB. CPAP, is a noninvasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. Co.'s products consist of airflow generators, diagnostic products, mask systems, headgear and other accessories.
Competitors
Stock Quote
Board of Directors
Dr. Peter C. Farrell Ph.D. Executive Chairman
Dr. Gary W. Pace Ph.D.
Mr. Ronald R. Taylor
Mr. Kieran T. Gallahue
Mr. Michael A. Quinn
Mr. Richard Sulpizio
Dr. Christopher G. Roberts Ph.D.
Mr. John P. Wareham
NAICS Code
Surgical and Medical Instrument Manufacturing: 339112
Industry Transcripts by Seeking Alpha
-
Healthways, Inc., F1Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 08, 2009about HWAY
-
Prospect Medical Holdings, Inc. Q4 2008 (Qtr End 09/30/08) Earnings Call Transcript
on Jan 08, 2009about PZZ
-
Teleflex Incorporated 2009 Financial Outlook Call Transcript
on Jan 08, 2009about TFX
-
AngioDynamics Inc., F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009about ANGO
-
Centene Corporation 2009 Financial Guidance Call Transcript
on Dec 19, 2008about CNC
